Balsam fir (Abies balsamea) needles and their essential oil kill overwintering ticks (Ixodes scapularis) at cold temperatures

Autor: Shelley A. Adamo, Amal El Nabbout, Laura V. Ferguson, Jeffrey S. Zbarsky, Nicoletta Faraone

Publikováno v: Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)

Abstract The blacklegged tick, Ixodes scapularis, vectors Borrelia burgdorferi, a bacterium that causes Lyme Disease. Although synthetic pesticides can reduce tick numbers, there are concerns about their potential effects on beneficial insects, such

Externí odkaz: https://doaj.org/article/bb3fe0f4cc744d7396c385b307b5b371

Female ticks ( Ixodes scapularis ) infected with Borrelia burgdorferi have increased overwintering survival, with implications for tick population growth

Autor: Amal El Nabbout, Laura V. Ferguson, Atsushi Miyashita, Shelley A. Adamo

Publikováno v: Insect Science.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8dc34b4e95bbcc12fc3fedac5c21a094
https://doi.org/10.1111/1744-7917.13205

Female ticks (Ixodes scapularis) infected withBorrelia burgdorferihave increased overwintering survival, with implications for tick population growth

Autor: Amal El Nabbout, Laura V. Ferguson, Atsushi Miyashita, Shelley A. Adamo

The tick,Ixodes scapularis, vectors pathogens such asBorrelia burgdorferi, the bacterium that causes Lyme Disease. Over the last few decadesI. scapularishas expanded its range, introducing a novel health threat into these areas. Warming temperatures

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::35992d46e469793bd81ab055e098f339
https://doi.org/10.1101/2022.12.07.519462

Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer

Autor: R. C. Coombes, P. D. Badman, J. P. Lozano-Kuehne, X. Liu, I. R. Macpherson, I. Zubairi, R. D. Baird, N. Rosenfeld, J. Garcia-Corbacho, N. Cresti, R. Plummer, A. Armstrong, R. Allerton, D. Landers, H. Nicholas, L. McLellan, A. Lim, F. Mouliere, O. E. Pardo, V. Ferguson, M. J. Seckl

Publikováno v: Nature Communications, 13(1):3246. Nature Publishing Group UK
Coombes, R C, Badman, P D, Lozano-Kuehne, J P, Liu, X, Macpherson, I R, Zubairi, I, Baird, R D, Rosenfeld, N, Garcia-Corbacho, J, Cresti, N, Plummer, R, Armstrong, A, Allerton, R, Landers, D, Nicholas, H, McLellan, L, Lim, A, Mouliere, F, Pardo, O E & Seckl, M J 2022, ' Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer ', Nature Communications, vol. 13, no. 1, 3246 . https://doi.org/10.1038/s41467-022-30666-0, https://doi.org/10.1038/s41467-022-30666-0

We conducted a phase IIa, multi-centre, open label, single arm study (RADICAL; NCT01791985) of AZD4547 (a potent and selective inhibitor of Fibroblast Growth Factor Receptor (FGFR)-1, 2 and 3 receptor tyrosine kinases) administered with anastrozole o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf41360879c66a88fb3325689e8e6361

Recent advances in central cardiovascular control: sex, ROS, gas and inflammation [version 1; referees: 2 approved]

Autor: Pauline M. Smith, Alastair V. Ferguson

Publikováno v: F1000Research, Vol 5 (2016)

The central nervous system (CNS) in concert with the heart and vasculature is essential to maintaining cardiovascular (CV) homeostasis. In recent years, our understanding of CNS control of blood pressure regulation (and dysregulation leading to hyper

Externí odkaz: https://doaj.org/article/46c3d433914d4ec0b919312e3e320507